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AbstrAct
Listeriosis, an opportunistic food-borne disease 
caused by listeria monocytogenes, is infrequent and 
occurs preferentially in patients at the extremes of age, 
during pregnancy or in immunocompromised hosts. 
Most common manifestations are maternofoetal and 
neonatal infections, severe invasive presentations such as 
bacteraemia with or without central nervous system 
symptoms occuring preferentially in immunosuppressed 
patients and self-limited gastro-enteritis affecting healthy 
individuals. Exceptionally, focal infections such as chole-
cystitis are described. We report here a case of acute 
cholecystitis caused by listeria monocytogenes in an 
82-year-old woman. Thanks to a successful treatment: 
cholecystectomy and antimicrobial therapy (amoxicillin 
plus clavulanic acid), the patient soon recovered. This 
case-report provides an opportunity to review the cur-
rent literature concerning the association of listeria 
monocytogenes and cholecystitis. 
Key words: listeria monocytogenes – cholecystitis – gastro- 
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introduction
Listeriosis is caused by a Gram positive, intracellular 
motile bacillus, listeria monocytogenes (LM). This microorgan-
ism is ubiquitously found in various environments such as 
soil, water, vegetation, various food products and even in the 
faecal flora of mammals. LM can survive in a variety of adverse 
environmental conditions and thus can contaminate many 
food products even at refrigeration temperatures, such as 
cheese made with raw milk, raw vegetables, delicatessen 
products, meat, poultry, smoked fishes and “ready-to-eat” 
meals (1). Except in some cases, LM is the only human 
 pathogen among the six described species of the genus 
 listeria. Listeriosis occurs primarily in groups at-risks: new-
born infants, patients older than 60 years, pregnant women 
and patients with impaired cell-mediated immunity (AIDS, 
haematologic malignancy, organ transplantation, corticoster-
oid therapy, haemodialysis, diabetes mellitus …) (1). The 
annual incidence in Europe is 3 reported cases per million 
inhabitants; 30% of cases happen during pregnancy, proba-
bly related to a mild immunosuppression during gestation. 
This pathogen causes infrequent but severe food-borne dis-
eases, with a high case-fatality rate (20-30%) (2, 3). Most com-
mon invasive disease manifestations in adults are bacterae-
mia with or without central nervous system (CNS) infection, 
such as meningitis, meningoencephalitis and rhomben-
cephalitis, but symptoms of self-limited febrile gastro-enteri-
tis can also occur in immunocompetent hosts. Infants acquire 
the infection in two ways: (i) maternofoetal infection during 
pregnancy resulting in chorioamnionitis and delivery of sep-
tic infant or fetus, (ii) perinatal contamination leading to bac-
terial meningitis in newborn up to 3 weeks after exposure to 
infected birth canal. More rarely, localized forms are described: 
endocarditis, osteomyelitis, arthritis, conjunctivitis, endoph-
talmitis, peritonitis, splenic abscess, pleuropulmonary infec-
tions and skin infections (1). 
We report here the case of a patient with acute cholecys-
titis, where LM was the only isolated pathogen. We also 
review the current literature concerning some recent pro-
gress in the knowledge of infection and colonization of the 
human gastrointestinal tract by listeria monocytogenes.
cAse report
An 82-year-old woman, with a past medical history of hys-
terectomy and hypertension, was admitted to Emergency 
Department for evaluation of abdominal pain, nausea with-
out vomiting and diarrhoea. No fever was reported. On 
admission, the patient presented a supple abdomen but with 
a diffuse tenderness, no hepatosplenomegaly, no perturba-
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hepatic phases of listeriosis: a bile salt hydrolase (BSH) and a 
bile exclusion system (BilE). Bsh is a LM-specific putative gene 
encoding a protein able to hydrolyse conjugated bile salts (5). 
Several Gram-positive bacteria of the enteric microflora pro-
duce this enzyme, which protects them from bile salt toxicity 
and contributes to intestinal colonization. BilE is more likely 
to be an exclusion system, close to multidrug efflux pumps, 
known to play an important role in bile resistance in Gram-
negative microbes (6). Both bsh and bile genes are preceded 
by σB-dependent promoter sites and are transcriptionnally 
downregulated in a sigB mutant (4).
Some studies have investigated the replication of LM in 
gallbladder bile of murine and porcine models. Dowd, et al. (7) 
showed that when the pH of porcine gallbladder bile is reduced 
to pH 5.5, in order to mimic the release of bile within the small 
intestine, specific resistance mechanisms (BSH, BilE, and Sigma-
B) are essential for survival of the pathogen under these condi-
tions. Hardy, et al. (8) reported that LM can replicate in the 
murine gallbladder and demonstrated that its replication is 
extracellular and intraluminal. While many bacteria infect and 
cause disease in the gallbladder tissue, LM belongs to the rare 
pathogenic bacteria capable of growing in the asymptomatic 
gallbladder in an animal model. This finding makes it difficult 
to prove that LM really was the pathogen responsible for chol-
ecystitis in the reported case, as LM could have grown harm-
lessly in the gallbladder without illness. A positive blood cul-
ture, which wasn’t performed, would have provided direct 
evidence to the involvement of LM in the infection. At best, the 
absence of other pathogen isolated from the bile sample pro-
vides indirect evidence to the role of LM in the development 
of cholecystitis, which would have been strengthened if more 
samples had been collected and shown positive with LM.
Only a few cases of listerial cholecystitis have been 
reported in literature during the last thirty years (9-13). In most 
cases, cholecystitis occurs in patients older than 60-year-old, 
more often female than male, with or without an underlying 
disease such as diabetes or some form of immunosuppression. 
The first case, reported in 1971 (9), was a 60-year-old woman, 
with no underlying disease, where infection of the gallbladder 
was not suspected until the patient underwent surgery for 
chronic cholecystitis. Unexpectedly, LM was grown from a cul-
ture of the gallbladder. Our reported case has an antecedent 
of hysterectomy and hypertension, like another patient in a 
previous case (10) who underwent cholecystectomy by lapa-
rotomy. In that report, the Gram stain of the bile sample 
showed Gram-positive rods and the culture yielded only LM. 
A paper (11) reported two cases of localized infections of the 
gallbladder in patients (a man and a woman) where cholecys-
titis was diagnosed and bile samples positive with LM. In all 
these oldest cases (1971 to 1989), no blood culture was per-
formed and, as LM was only found in bile samples, his patho-
genic role in the development of cholecystitis is debatable. In 
more recent reports (12, 13), LM was isolated both from blood 
culture and bile samples or swab culture of the gallbladder. 
The three patients – one man and two women- were all receiv-
ing immunosuppressive therapy. Two of them developed sys-
temic listeriosis, including cholecystitis and CNS infection, 
shortly after initiation of a TNF-blocking therapy (12). In most 
cases, fever, abdominal pain, nausea and diarrhoea were 
described before disease occurrence. Serovar 4b, isolated from 
our patient’s bile sample, appears to be the most virulent of 
elevated leukocyte count and slightly elevated C-reactive 
protein (CRP). She was hospitalized for clinical surveillance 
and gastroenterological assessment. 
On day 2, worsening of the inflammatory syndrome was 
observed with increasing fibrinogen and CRP. She also had 
biological signs of hepatic cytolysis and cholestasis. Hepato-
megaly was noticed. Echography showed a cholecystitis with 
sludge and microlithisasis in the gallbladder, a bile duct dila-
tation and Murphy’s sign. An abdominal scanner confirmed a 
diagnosis of cholecystitis and showed a light ectasia of intra-
hepatic bile tracts and bile duct. An antibiotherapy by amox-
icillin plus clavulanic acid (AUGMENTIN®) was initiated. A chol-
ecystectomy was performed by laparoscopy on day 3. During 
surgery, the gallbladder showed signs of inflammation and 
peri-hepatic adhesions. Peroperative cholangiography was 
normal. Histological examination of the biliary mucosa 
brought to light inflammatory infiltrates and presence of 
necrotic tissue. Post operative follow up was favourable, as 
was the biological evolution. The patient was discharged 
from hospital on the eighth post-operative day. 
Unfortunately, no blood culture was performed during 
her hospital stay. Only one bile sample was collected during 
intervention: the Gram stain did not show any leukocyte or 
bacteria but the bile culture yielded a few colony forming 
units (CFU) of LM that were susceptible in vitro to penicillin, 
ampicillin, gentamicin, ciprofloxacin, vancomycin, erythromy-
cin and trimethoprim-sulfamethoxazole. The Belgian refer-
ence laboratory identified the strains as serotype 4b. 
discussion
listeria monocytogenes is a Gram-positive rod, able to sur-
vive and replicate in extreme environmental conditions 
(drought, high salinity and a wide range of pH levels and tem-
peratures). After ingestion, LM translocates through the intes-
tine to reach the mesenteric gland. LM then replicates in the 
spleen and in the liver. In patients with impaired cell- mediated 
immunity, LM is discharged into the blood flow and after-
wards replicates preferentially in the CNS or in the placenta 
of pregnant women. 
To reach, colonize and subsequently infect the gastro-
intestinal (GI) tract, LM encounters numerous micro- 
environmental conditions, including stomach acidity fol-
lowed by elevated osmolarity and exposure to bile salts in the 
upper small intestine. Sigma-B (σB) is a key factor involved in 
adaptation to GI environments: σB regulon is required for 
rapid induction of expression of LM genes most likely to be 
important for survival of GI stresses, including reduced pH, 
elevated osmolarity and bile salts (4). Given that sigB is tran-
scriptionnally upregulated at elevated osmolarity, the osmotic 
stress appears to be at the top of hierarchy of LM stress 
responses during GI transit. Furthermore, σB has recently been 
shown to modulate PrfA (positive regulatory factor A), the 
master regulator of virulence gene cluster which coordinates 
the intracellular phase of LM infection (4). 
Ability to tolerate high levels of bile stress is also a key 
challenge for LM. In addition to their role in digestion, bile 
salts have a cytotoxic effect by degrading the lipid-containing 
bacterial and viral membranes. Two major virulence factors 
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the three major serovars (1/2a, 1/2b and 4b) responsible for 
human listeriosis: indeed, all major outbreaks of invasive dis-
ease have been caused by LM serotype 4b. As for the treat-
ment, cholecystectomy and antibiotherapy with amoxicillin 
plus clavulanic acid was successful. in vitro data and in vivo 
clinical experience suggest that ampicillin is the most effective 
therapeutic agent, in combination with an aminoglycoside for 
the treatment of invasive listeriosis. For those intolerant to 
penicillins, trimethoprim-sulfamethoxazole appears to be the 
best alternative (1). All strains of LM are uniformly resistant to 
cephalosporins: consequently, as third-generation cephalo-
sporins are commonly used in empirical treatment of bacterial 
meningitis, combination with ampicillin must be used when 
listerial meningitis is suspected.
In conclusion, we present here the case of an acute chol-
ecystis probably caused by LM in an 82-year-old woman who 
soon recovered thanks to a treatment by cholecystectomy 
and antibiotics (amoxicillin plus clavulanic acid). The recent 
discoveries about infection and colonization of the GI tract by 
LM stress the need for specimen collection (especially blood 
culture) to prove the pathogenic role of LM in gallbladder 
infection.
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